PSG2 and non-small cell lung carcinoma: CEA was shown as a prognostic biomarker for BM, as well as cytokeratin 19 fragments (CYFRA 21-1), cancer antigen 125 (CA125), cancer antigen 19-9 (CA19-9), and squamous cancer cell antigen in NSCLC [153].